This study aims to investigate the clinical feasibility of abbreviated liver MRI for HCC surveillance in a high-risk group.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
257
Biannual liver ultrasonography for HCC surveillance, without contrast agent.
Abbreviated liver MRI using standard dose of extracellular contrast agent (Dotarem, Guerbet, France) on weight-based dosing. Table time targets 10 minutes.
Seoul National University Hospital
Seoul, South Korea
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
Sensitivity for detecting HCC
Sensitivity for detecting HCC
Time frame: 12 months after last MRI
Table time of abbreviated MRI
time from scan start and scan end
Time frame: 1 day after each MRI
In-room time of abbreviated MRI
interval between participants' walk-in and walk-out times
Time frame: 1 day after each MRI
Specificity for detecting HCC
Specificity for detecting HCC
Time frame: 12 months after last MRI
Sensitivity for detecting early stage HCC
Sensitivity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)
Time frame: 12 months after last MRI
Specificity for detecting early stage HCC
Specificity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)
Time frame: 12 months after last MRI
Image quality of abbreviated liver MRI
qualitative analysis on four-point scale
Time frame: 12 months after last MRI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.